What's In Store For Crocs Q3 Earnings? Analyst Eyes North America Trends BofA Securities analyst Christopher Nardone reiterated the Buy rating on Crocs, Inc (NASDAQ:CROX), with a price objective of $179. The company said it will discuss the results of its third quarter on Tuesday, October 29. Nardone cites an attractive risk/reward for the stock that is pegged at a 10x P/E ratio. The analyst projects third-quarter earnings per share (EPS) of $3.17, slightly exceeding the guidance range of $2.95 to $3.10 and 2% above consensus estimates. This forecast includes a 5.8% growth in Crocs sales, surpassing the guidance of 3% to 5%, driven by strong international performance, while Heydude sales are expected to decline by 15%, in line with guidance. Also Read: Netflix ‘Should Continue To Outperform’: 6 Analysts On Streaming Stock’s Q3 Earnings Nardone writes attention will be focused this quarter on trends in North America and whether the shift to direct-to-consumer (DTC) sales following the Amazon.com, Inc. transition in September will result in negative DTC trends. Confirmation that North America sales are stable or modestly higher would alleviate concerns regarding what the analyst considers the main debate surrounding the stock. In previous years, Crocs has adjusted its sales outlook upward (three times) and its margins (twice) in January compared to the initial fourth-quarter guidance. The analyst forecasts another conservative forecast, projecting fourth-quarter earnings per share of $2.66, which would raise the fiscal 2024 EPS estimate to $12.86, aligning with the high end of the guidance range. According to Benzinga Pro, CROX stock has gained over 62% in the past year. Investors can gain exposure to the stock via Advisors Series Trust VegTech Plant-based Innovation & Climate ETF (NYSE:EATV) and Advisor Managed Portfolios Miller Value Partners Appreciation ETF (NYSE:MVPA). Price Action: CROX shares are trading higher by 1.72% to $138.43 at last check Friday. Image via Pexels Read Next: Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season Latest Ratings for CROX Date Firm Action From To Feb 2022 Loop Capital Maintains Buy Jan 2022 B. Riley Securities Maintains Buy Jan 2022 Seaport Global Initiates Coverage On Neutral View More Analyst Ratings for CROX View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? CROCS (CROX): Free Stock Analysis Report This article What's In Store For Crocs Q3 Earnings? Analyst Eyes North America Trends originally appeared on Benzinga.com © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
What's In Store For Crocs Q3 Earnings? Analyst Eyes North America Trends
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...